Hemoglobin A; Glycosylated (D12.776.422.316.762.380.440); Hemoglobin A; Glycosylated (D12.776.124.400.405.440); Hemoglobin A; Glycosylated (D09.408.375); Diabetes Mellitus; Type 2 (C19.246.300); Therapeutic Uses (D27.505.954); Metformin (D02.078.370.141.450); Thiazolidinediones (D02.886.675.933); Dipeptidyl Peptidase 4 (D23.050.301.264.035.283); Diabetes Mellitus (C19.246); Drug Therapy; Combination (E02.319.310); Dipeptidyl-Peptidase IV Inhibitors (D27.505.696.422.500); Sodium-Glucose Transporter 2 (D12.776.157.530.500.750.750); Sodium-Glucose Transporter 2 (D12.776.543.585.500.750.750); Dipeptidyl-Peptidase IV Inhibitors (D27.505.519.389.745.335)
The library contains links to guidelines published or endorsed by GIN member organisations from across the globe. It also contains a registry of planned guidelines and guidelines in development. Non members are actively encouraged to register their guidelines in development. Contact [email protected] to find out how. To learn more about GIN and membership, click the website button above.